Podcast Episodes

Coffee, Chips, and Credit Cards

Earnings from Starbucks, Visa, and Spotify’s earnings give us a read on the consumer and Samsung takes a big chip order from Tesla. 

(00:21) Travis H…

5 months, 1 week ago

A Rough Day for Dividend Knights

Between battered industries and overlooked opportunities, plenty of dividend-paying companies have slipped to the bottom of the earnings jar. Today, …

5 months, 1 week ago

Intel Can’t Stop Cutting

The former Chip King is cutting again in hopes of finding a path to sustainable growth.

Tim Beyers and Jose Najarro discuss:

- Intel’s big restructur…

5 months, 1 week ago

What Business School is Missing

So, what is the role of business? Motley Fool contributor Rich Lumelleau and Motley Fool analyst Dave Meier talk with Andy Hoffman, Professor at Univ…

5 months, 1 week ago

Choosing a 529 and How Does Your 401(k) Compare

529 plans aren’t just for college anymore. Robert Brokamp speaks with Martha Kortiak Mert of Savingforcollege.com about the newly expanded uses of 52…

5 months, 2 weeks ago

Meme Stocks Mania Returns & the Fantasy Stock Draft

Meme stocks had a huge week, earnings season got into full swing with Alphabet going big on AI, and we draft our top stocks in the S&P 500 today.

Tr…

5 months, 2 weeks ago

Earnings Season Is in Full Swing, and Figma's IPO Is Right Around the Corner

Matt Frankel, Tom Gardner, Jon Quast, and Jonathan Wilder discuss:

- Earnings disappointments from Tesla and Chipotle

- AI-powered growth from Alphab…

5 months, 2 weeks ago

Japan Gets a Trade Deal and Earnings Season Ramps Up

The U.S. and Japan announced a big trade deal that lowers tariffs to just 15% on imports, and we discuss earnings from General Motors, Intuitive Surg…

5 months, 2 weeks ago

Block Party and Big Swings

With Block joining the S&P500 and Figma pricing its IPO, investors may be wondering if they should be rising with the tide or fishing where others ar…

5 months, 2 weeks ago

Has Biotech Met Its Moment?

A surge in private market investment has Fools wondering: is it time to bet bigger on biotech?

Tim Beyers and Karl Thiel discuss:

- The rise in bio…

5 months, 2 weeks ago